T43.212 Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm

Name of the Condition

• Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm

Summary

This condition involves intentional self-harm resulting from exposure to selective serotonin and norepinephrine reuptake inhibitors (SNRIs), a class of antidepressant medications. It is identified by clinical presentation, medication history, and the nature of the exposure. The diagnosis is based on confirmation of intentional self-harm and the presence of SNRIs.

Causes

Intentional self-harm occurs when an individual purposefully ingests an excessive amount of SNRIs, typically as a deliberate act of self-harm. This may involve taking more than the prescribed dose or consuming medication not intended for them.

Risk Factors

• History of mental health conditions, such as depression or anxiety, increasing self-harm risk.
• Prior episodes of self-harm or suicidal behavior.
• Access to medications without supervision.
• Social or environmental stressors contributing to emotional distress.

Symptoms

• Nausea, vomiting, or abdominal pain
• Dizziness, drowsiness, or confusion
• Rapid heart rate or changes in blood pressure
• Tremors, seizures, or muscle rigidity
• Excessive sweating or fever
• Respiratory depression or failure (in severe cases)

Diagnosis

Diagnosis is based on a thorough patient history, including medication use and circumstances of exposure, along with clinical assessment of symptoms. Laboratory tests may be used to confirm the presence of SNRIs or rule out other causes. Documentation of intentional self-harm is critical for accurate coding.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing the underlying mental health concerns. This may include activated charcoal, supportive care, and psychiatric evaluation. Long-term management often involves therapy and medication adjustments.

Prognosis and Follow-Up

Prognosis depends on the severity of the poisoning and the timeliness of treatment. Follow-up care typically includes ongoing psychiatric support and monitoring for recurrence of self-harm behaviors. Early intervention improves outcomes.

Complications

• Seizures or neurological damage
• Respiratory failure requiring mechanical ventilation
• Cardiac arrhythmias or heart failure
• Kidney or liver injury from toxin accumulation
• Increased risk of future self-harm or suicide

Lifestyle & Prevention

• Secure storage of medications to prevent access.
• Regular mental health check-ins and therapy.
• Education on medication safety and overdose risks.
• Support from family, friends, or support groups.

When to Seek Professional Help

Seek immediate medical attention if self-harm is suspected or if symptoms of poisoning (e.g., confusion, seizures, difficulty breathing) occur. Contact emergency services or a healthcare provider promptly.

Tips for Medical Coders

This code is specific to intentional self-harm from SNRIs. Ensure documentation clearly indicates the intentional nature of the exposure and the involvement of SNRIs. Differentiate from accidental or adverse effect scenarios to avoid miscoding. Verify the clinical context and medication history to support accurate assignment.